Functional assays further demonstrated that the prometastatic effects of POLR3G were mediated through this pathway, both in vitro and in vivo, establishing POLR3G as a critical effector of EMT and metastasis in bladder cancer [57]. This evidence concerns the gene POLR3G and urinary bladder cancer.